High Note Wealth’s CONMED CNMD Stock Holding History

High Note Wealth’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22	Closed	-$1.33K	–	899
2025 Q1	$1.33K	Buy	+22	New	+$1.42K	﹤0.01%	734

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

High Note Wealth's CNMD Position: Q2 2025 in Review

High Note Wealth sold out of CONMED (CNMD) in Q2 2025, closing a stake of 22 shares — an estimated $1.33K sold.

High Note Wealth first reported a position in CNMD in Q1 2025 and held it in 1 quarter. The position peaked at $1.33K in Q1 2025. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

High Note Wealth reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
High Note Wealth sold 22 CONMED shares in Q2 2025, an estimated $1.33K.
High Note Wealth first reported a position in CONMED in Q1 2025 and held it in 1 quarter.
High Note Wealth's CONMED position peaked at $1.33K in Q1 2025.
276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on High Note Wealth's 13F filing for Q2 2025, filed 23 Jul 2025.